(Q35981405)

11 August 2017

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days (English)

1 reference

11 August 2017

1 reference

1 reference

Mulder PO

1

1 reference

11 August 2017

de Vries EG

2

1 reference

11 August 2017

Uges DR

3

1 reference

11 August 2017

Scaf AH

4

1 reference

11 August 2017

Sleijfer DT

5

1 reference

11 August 2017

Mulder NH

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

61

1 reference

11 August 2017

3

1 reference

11 August 2017

460-464

1 reference

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Phase I clinical and pharmacologic trial of carboplatin daily for 5 days

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Phase I study of carboplatin given on a five-day intravenous schedule

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Carboplatin: the clinical spectrum to date

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Statistical estimations in pharmacokinetics.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Renal dysfunction following high-dose carboplatin treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Pharmacokinetic analyses with RUGFIT: an interactive pharmacokinetic computer program

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

Drug therapy. Clinical Pharmacokinetics (first of two parts).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971298

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells

11 July 2018

1 reference

12 December 2020

Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin

1 reference

12 December 2020

Protein binding of five platinum compounds. Comparison of two ultrafiltration systems

1 reference

12 December 2020

In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin

1 reference

12 December 2020

Chemical reactivity of cisplatin bound to human plasma proteins

1 reference

12 December 2020

Pharmacokinetics of carboplatin after i.v. administration

1 reference

12 December 2020

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

1 reference

12 December 2020

Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry

1 reference

12 December 2020

Kinetics of cis-dichlorodiammineplatinum

1 reference

12 December 2020

Mechanism of cisplatin nephrotoxicity

1 reference

12 December 2020

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.101

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

2183874

1 reference